Dexmedetomidine Injection, Solution
Product Images NDC 71288-505

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexmedetomidine (NDC 71288-505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Dex18 0000 01)

FDA Label Image

Principal Display Panel – Dexmedetomidine Injection, Usp 200 Mcg Per 2 mL Vial Label (Dex18 0000 02)

This is a prescription medication with the NDC number NDC71288-505-02. It is an injection in USP form, containing 200 micrograms of Dexmedetomidine BASE in a 2 mL single-dose vial. The injection must be diluted before intravenous use. The manufacturer is Meitheal Pharmaceuticals, located in Chicago, IL 60631, USA. ©2020 Meitheal Pharmaceuticals Inc.*

FDA Label Image

Principal Display Panel – Dexmedetomidine Injection, Usp 200 Mcg Per 2 mL Carton (Dex18 0000 03)

This text is a medical description of an injectable medication containing dexmedetomidine and sodium chloride, used for intravenous use. It comes in sterile and preservative-free single-dose vials, each mL containing 100 mcg of dexmedetomidine base and 9 mg of sodium chloride in water. The medication is stable chemically and has a pH of 4.5 - 7.0. The medication should be stored between 15 - 30°C and should not be used if the container is not intact. The text provides additional details such as the manufacturer's name, packaging information, and a prescription label.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.